141 related articles for article (PubMed ID: 38756206)
1. The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults.
Iwamoto SJ; Rice JD; Moreau KL; Cornier MA; Wierman ME; Mancuso MP; Gebregzabheir A; Hammond DB; Rothman MS
J Clin Transl Endocrinol; 2024 Jun; 36():100348. PubMed ID: 38756206
[TBL] [Abstract][Full Text] [Related]
2. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
3. Bone Density in Transgender Youth on Gender-Affirming Hormone Therapy.
Roy MK; Bothwell S; Kelsey MM; Ma NS; Moreau KL; Nadeau KJ; Rothman MS; Nokoff NJ
J Endocr Soc; 2024 Mar; 8(5):bvae045. PubMed ID: 38562129
[TBL] [Abstract][Full Text] [Related]
4. Body Composition and Metabolic Syndrome Components in Transgender/Gender Diverse Adolescents and Young Adults.
Borger O; Perl L; Yackobovitch-Gavan M; Sides R; Brener A; Segev-Becker A; Sheppes T; Weinstein G; Oren A; Lebenthal Y
LGBT Health; 2024 Apr; ():. PubMed ID: 38557208
[No Abstract] [Full Text] [Related]
5. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
6. Increased Bone Mineral Density in Male Patients With Idiopathic Hypogonadotropic Hypogonadism Who Undergo Sex Hormone Therapy: Findings From Cross-Sectional and Longitudinal Studies.
Zhang R; Mao J; Wang X; Nie M; Ma W; Ji W; Yu B; Huang Q; Wu X
Endocr Pract; 2021 Sep; 27(9):934-940. PubMed ID: 34000389
[TBL] [Abstract][Full Text] [Related]
7. Effects of serum 25-hydroxyvitaminD level on decreased bone mineral density at femoral neck and total hip in Chinese type 2 diabetes.
Guo L; Gao Z; Ge H
PLoS One; 2017; 12(11):e0188894. PubMed ID: 29190676
[TBL] [Abstract][Full Text] [Related]
8. Study of Effects of Gender-Affirming Hormone Therapy on Bone Mineral Density in Individuals with Gender Dysphoria.
Bobba R; Kalra P; Dharmalingam M
Indian J Endocrinol Metab; 2023; 27(6):486-491. PubMed ID: 38371188
[TBL] [Abstract][Full Text] [Related]
9. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
11. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
13. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
[TBL] [Abstract][Full Text] [Related]
14. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
[TBL] [Abstract][Full Text] [Related]
15. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
Joseph T; Ting J; Butler G
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1077-1081. PubMed ID: 31472062
[TBL] [Abstract][Full Text] [Related]
16. Changes in bone mineral density over time by body mass index in the health ABC study.
Lloyd JT; Alley DE; Hochberg MC; Waldstein SR; Harris TB; Kritchevsky SB; Schwartz AV; Strotmeyer ES; Womack C; Orwig DL;
Osteoporos Int; 2016 Jun; 27(6):2109-16. PubMed ID: 26856584
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
[TBL] [Abstract][Full Text] [Related]
18. Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly.
Murray RD; Columb B; Adams JE; Shalet SM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1124-30. PubMed ID: 15001597
[TBL] [Abstract][Full Text] [Related]
19. Bone Health in the Transgender and Gender Diverse Youth Population.
Lee JY
Curr Osteoporos Rep; 2023 Aug; 21(4):459-471. PubMed ID: 37395890
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of bone mineral density in patients with functional hypothalamic amenorrhoea and its association with reproductive hormones and body composition.
Lu Y; Lu P; Lin L; Chen H; Zhang F; Li X
Clin Endocrinol (Oxf); 2024 Apr; 100(4):358-365. PubMed ID: 38229276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
